Literature DB >> 29872555

Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival.

Mariana Brutschin Pereira1,2, Luciana Rodrigues Carvalho Barros3, Paula A Bracco4, Alvaro Vigo5,4, Mariana Boroni6, Martín Hernán Bonamino3,7, Guido Lenz1,2.   

Abstract

Introduction: Several cell populations from the peripheral immune system interact to create a complex immunologic status during glioblastoma growth and response to therapy. The aim of this study was to integrate the impact of different immune cell populations present in glioblastoma tumor microenvironment on overall survival. Methodology: Gene expression and clinical data were generated by The Cancer Genome Atlas and previously reported meta-signatures representing cells of the immune system were used. The relationship between meta-signatures was evaluated through Pearson's correlation analyses. Survival analyses were performed through Kaplan-Meier plots and Cox regression model. Results and discussion: Meta-signatures corresponding to infiltrating immune cells with immunosuppressive roles, such as macrophages, NK and NK T cells, MDSCs and Tregs, correlated with poorer patient prognosis. Meta-signatures related to CD8+ T cells predicted improved survival only in patients with low immunosuppressive meta-signatures. By clustering the meta-signatures we found that the cluster containing high meta-signatures of macrophages, MDSCs and Tregs demonstrated the worst prognosis.
Conclusion: Integrating the information provided by transcriptional signatures of immunological aspects is fundamental in understanding the impact of the immune system on patient survival. We found a predictive impact on survival with positive role for CD8 and negative roles for macrophages, MDSC, Tregs, NK and NK-T in glioblastoma patients. Understanding these regulatory and stimulatory factors of patients' immune system is essential to delineate an effective strategy to increase the anti-tumor immune response and to generate potential clinical benefits.

Entities:  

Keywords:  Exhaustion; Glioblastoma; Glioma; immunotherapy; meta-signatures

Year:  2018        PMID: 29872555      PMCID: PMC5980418          DOI: 10.1080/2162402X.2018.1431083

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  58 in total

1.  Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

Authors:  Michael Gobert; Isabelle Treilleux; Nathalie Bendriss-Vermare; Thomas Bachelot; Sophie Goddard-Leon; Vanessa Arfi; Cathy Biota; Anne Claire Doffin; Isabelle Durand; Daniel Olive; Solène Perez; Nicolas Pasqual; Christelle Faure; Isabelle Ray-Coquard; Alain Puisieux; Christophe Caux; Jean-Yves Blay; Christine Ménétrier-Caux
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

2.  Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers.

Authors:  Michael Prosniak; Larry A Harshyne; David W Andrews; Lawrence C Kenyon; Kamila Bedelbaeva; Tatiyana V Apanasovich; Ellen Heber-Katz; Mark T Curtis; Paolo Cotzia; D Craig Hooper
Journal:  Clin Cancer Res       Date:  2013-06-05       Impact factor: 12.531

3.  History of allergies among adults with glioma and controls.

Authors:  Joseph L Wiemels; John K Wiencke; Jennette D Sison; Rei Miike; Alex McMillan; Margaret Wrensch
Journal:  Int J Cancer       Date:  2002-04-01       Impact factor: 7.396

Review 4.  Myeloid-derived suppressor cells in human cancer.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

Review 5.  A malignant astrocytoma in a patient with AIDS: a possible association between astrocytomas and HIV infection.

Authors:  J W Neal; M B Llewelyn; H L Morrison; B Jasani; L K Borysiewicz
Journal:  J Infect       Date:  1996-11       Impact factor: 6.072

Review 6.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

Review 8.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

Authors:  Gavin P Dunn; Ian F Dunn; William T Curry
Journal:  Cancer Immun       Date:  2007-08-13

9.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

10.  Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model.

Authors:  Konrad Gabrusiewicz; Mohammad B Hossain; Nahir Cortes-Santiago; Xuejun Fan; Bozena Kaminska; Frank C Marini; Juan Fueyo; Candelaria Gomez-Manzano
Journal:  Neoplasia       Date:  2015-04       Impact factor: 5.715

View more
  14 in total

Review 1.  In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission Tomography.

Authors:  Cristina Barca; Claudia Foray; Bastian Zinnhardt; Alexandra Winkeler; Ulrich Herrlinger; Oliver M Grauer; Andreas H Jacobs
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

2.  Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.

Authors:  Yaoqing Shen; Cameron J Grisdale; Sumaiya A Islam; Pinaki Bose; Jake Lever; Eric Y Zhao; Natalie Grinshtein; Yussanne Ma; Andrew J Mungall; Richard A Moore; Xueqing Lun; Donna L Senger; Stephen M Robbins; Alice Yijun Wang; Julia L MacIsaac; Michael S Kobor; H Artee Luchman; Samuel Weiss; Jennifer A Chan; Michael D Blough; David R Kaplan; J Gregory Cairncross; Marco A Marra; Steven J M Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-30       Impact factor: 11.205

Review 3.  Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications.

Authors:  Jun Wei; Peiwen Chen; Pravesh Gupta; Martina Ott; Daniel Zamler; Cynthia Kassab; Krishna P Bhat; Michael A Curran; John F de Groot; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

4.  Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer.

Authors:  Sheng Yang; Tong Liu; Yanping Cheng; Yunfei Bai; Geyu Liang
Journal:  Cancer Sci       Date:  2019-11-02       Impact factor: 6.716

Review 5.  Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End.

Authors:  Angeliki Datsi; Rüdiger V Sorg
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

6.  Decreased CD8+ Lymphocytic Infiltration in Multifocal and Multicentric Glioblastomas.

Authors:  Run Wang; Yifu Song; Tianhao Hu; Xiaoliang Wang; Yang Jiang; Di Zhang; Juanhan Yu; Sheng Han; Liang Kan
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

Review 7.  Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside.

Authors:  Yutao Li; Amit Sharma; Jarek Maciaczyk; Ingo G H Schmidt-Wolf
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

8.  An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.

Authors:  Yang Xu; Renpeng Li; Xiaoxia Li; Naijun Dong; Di Wu; Lin Hou; Kan Yin; Chunhua Zhao
Journal:  Front Oncol       Date:  2020-10-19       Impact factor: 6.244

9.  Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.

Authors:  Astrid De Boeck; Bo Young Ahn; Charlotte D'Mello; Xueqing Lun; Shyam V Menon; Mana M Alshehri; Frank Szulzewsky; Yaoqing Shen; Lubaba Khan; Ngoc Ha Dang; Elliott Reichardt; Kimberly-Ann Goring; Jennifer King; Cameron J Grisdale; Natalie Grinshtein; Dolores Hambardzumyan; Karlyne M Reilly; Michael D Blough; J Gregory Cairncross; V Wee Yong; Marco A Marra; Steven J M Jones; David R Kaplan; Kathy D McCoy; Eric C Holland; Pinaki Bose; Jennifer A Chan; Stephen M Robbins; Donna L Senger
Journal:  Nat Commun       Date:  2020-10-05       Impact factor: 14.919

10.  Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer.

Authors:  Gaoteng Lin; Jianwei Zhang; Yuqi Wu; Shimiao Zhu; Gang Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.